Anglo-Swedish pharma major AstraZeneca has presented positive top-line results from the Phase III KALOS and LOGOS trials in ...

US biotech Jazz Pharmaceuticals (Nasdaq: JAZZ) is banking on continued growth from Epidiolex (cannabidiol), the first ...

Danish drugmaker Novo Nordisk (NOV: N) has secured a significant advantage in the high-stakes obesity drug market after ...

The head of the World Health Organization has issued a stark warning that sudden cuts to global health budgets, including by ...

Clinical-stage biopharma company Satsuma Pharmaceuticals and its corporate parent, Shin Nippon Biomedical (TYO: 2395), ...

US biotech major Amgen (Nasdaq AMGN) late Thursday announced financial results for the first quarter of 2025, revealing that ...

Cidara Therapeutics, a San Diego biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) ...

The US Department of Health and Human Services has announced a sweeping change to the way new vaccines are evaluated, saying ...

Shares in Kronos Bio, a US biotech that has been developing small molecule therapeutics to address cancers and other diseases ...

Mergers and acquisitions (M&As) in the biopharmaceutical industry surged 101% in total deal value in first-quarter 2025 from ...

A new report from Washington DC-based group No Patient Left Behind argues that foreign governments are underestimating the value of innovative medicines — a claim that adds fuel to the ongoing ...

The Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Vimkunya, a vaccine used to prevent disease caused by the chikungunya virus in people 12 years of age and older. The ...